PLEASANTON, Calif. — Microchip Biotechnologies, a maker of automated microscale biotech laboratory systems, today announced that it has changed its business name to IntegenX. The new name articulates the company’s focus on integrating sample preparation and analysis technologies into complete products that address generic problems shared by life science and biotechnology research laboratories worldwide. Under […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced that it has sequenced the DNA of American actress Glenn Close, the first publicly named female to have her DNA sequenced to full coverage. The service was completed in Illumina’s CLIA certified and CAP accredited laboratory utilizing Illumina’s Genome Analyzer technology and following the established process shown at https://www.everygenome.com/. […]
The Department of Obstetrics and Gynecology in collaboration with the Applied Genomics Technology Core have generated a considerable amount of data about cis and epigenetic elements that control many reproductive events, including cell-fate Munich (Germany), Ann Arbor, MI (USA) — The C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology, at […]
Source BioScience plc (LSE: SBS), the provider of expert, quality services to the life science research, pharma biotech and healthcare sectors, is pleased to announce the purchase of Illumina’s new HiSeq 2000 high throughput next generation sequencing platform, the first laboratory in the UK to do so. This investment will further strengthen Source BioScience’s existing […]
SOUTH SAN FRANCISCO, Calif.–Fluidigm Corporation today announced the release of 5kb and 10kb long-range PCR protocols for its Access Array™ System. Researchers interested in targeted re-sequencing projects for large cohort studies can use these new protocols and the Fluidigm Access Array System to amplify up to 48 samples per array. Long-range PCR enables new applications […]
First-of-Its-Kind Project Will Sequence Difficult Breast Cancers to Provide Insight into Treatment Strategies CARLSBAD, Calif., PHOENIX & THE WOODLANDS, Texas–Life Technologies Corporation (NASDAQ:LIFE) today announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have […]
MENLO PARK, Calif.–Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the appointment of Susan K. Barnes as Chief Financial Officer. “Given the tremendous number of possible business opportunities we have for commercializing our Single Molecule Real Time (SMRT™) technology, her experience […]
CARLSBAD, Calif.–Life Technologies Corporation (NASDAQ:LIFE) today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories […]
BOZEMAN, Mont.–Golden Helix, Inc., a global leader in genetic analysis solutions, today announced it has partnered with Millennium Science Pty Ltd, a leading life sciences distributor in Australia and New Zealand, to provide sales and support for the company’s SNP & Variation Suite, an advanced analytic software package for genetic research. The partnership better positions […]
Reduce Sequencing Costs Up to 16-Fold MARCO ISLAND, Fla.–AGBT–Agilent Technologies Inc. (NYSE:A) today announced that its Agilent SureSelect Target Enrichment System supports multiplexed DNA sequencing of 12 to 16 samples per lane depending on the next-generation sequencing platform, reducing costs and increasing throughput up to 16-fold. “We originally designed the Agilent SureSelect Target Enrichment System […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
